caffeine has been researched along with Weight Loss in 73 studies
Weight Loss: Decrease in existing BODY WEIGHT.
Excerpt | Relevance | Reference |
---|---|---|
"The objective of this study was to examine the effect of caffeine on judo performance, perceived exertion, and plasma lactate response when ingested during recovery from a 5-day weight loss period." | 9.19 | Caffeine ingestion after rapid weight loss in judo athletes reduces perceived effort and increases plasma lactate concentration without improving performance. ( Bertuzzi, R; Felippe, LJ; Lima-Silva, AE; Lopes-Silva, JP; Silva-Cavalcante, MD, 2014) |
"To evaluate the effects of combination caffeine/ephedrine and leptin A-200 on visceral fat mass and weight loss over 24 weeks." | 9.17 | The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss. ( Fujioka, K; Greenway, FL; Liu, AG; Smith, SR, 2013) |
"Green tea (epigallocatechin gallate + caffeine) and protein each were shown to improve body weight maintenance after weight loss." | 9.14 | Green tea catechin plus caffeine supplementation to a high-protein diet has no additional effect on body weight maintenance after weight loss. ( Hursel, R; Westerterp-Plantenga, MS, 2009) |
"Investigation of the effect of a green tea-caffeine mixture on weight maintenance after body weight loss in moderately obese subjects in relation to habitual caffeine intake." | 9.11 | Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. ( Kovacs, EM; Lejeune, MP; Westerterp-Plantenga, MS, 2005) |
"Caffeine ingestion decreases the insulin sensitivity index (ISI) for an oral-glucose-tolerance test (OGTT) and decreases insulin-induced glucose disposal in lean male subjects during a hyperinsulinemic clamp." | 9.11 | Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss. ( Belfie, LM; Chown, SE; Conquer, JA; Duncan, AM; Graham, TE; McLaren, DH; Petrie, HJ, 2004) |
"To examine long-term safety and efficacy for weight loss of an herbal Ma Huang and Kola nut supplement (90/192 mg/day ephedrine alkaloids/caffeine)." | 9.10 | Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. ( Blanchard, D; Boozer, CN; Daly, PA; Homel, P; Meredith, T; Nasser, JA; Solomon, JL; Strauss, R, 2002) |
"To compare caffeine pharmacokinetics (200 mg single oral dose) between obese and lean subjects and in obese subjects prior to and following weight reduction." | 9.08 | Caffeine pharmacokinetics in obesity and following significant weight reduction. ( Berry, EM; Caraco, Y; Levy, M; Zylber-Katz, E, 1995) |
"In previous separate studies, dexfenfluramine (DF) and ephedrine/caffeine (EC) have been shown to promote weight loss in obese patients as compared with placebo." | 9.07 | Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice. ( Ahlstrøm, F; Breum, L; Frimodt-Møller, J; Pedersen, JK, 1994) |
"This systematic review and meta-analysis of randomized controlled trials (RCTs) was performed to summarize the effect of caffeine intake on weight loss." | 9.01 | The effects of caffeine intake on weight loss: a systematic review and dos-response meta-analysis of randomized controlled trials. ( Akbari, M; Asemi, Z; Esmaillzadeh, A; Kolahdooz, F; Lankarani, KB; Mazoochi, M; Nadi-Ravandi, S; Saneei, P; Tabrizi, R, 2019) |
"Ephedra and ephedrine sometimes are used for weight loss or enhanced athletic performance, but the efficacy and safety of these compounds are uncertain." | 8.82 | Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. ( Gagné, J; Hardy, ML; Jungvig, L; Maglione, M; Mojica, WA; Morton, SC; Rhodes, SL; Shekelle, PG; Suttorp, MJ, 2003) |
"Since passage of the Dietary Supplement Health and Education Act of 1994, the sale of herbal dietary supplements containing caffeine and ephedrine for weight loss has become widespread in the United States." | 8.81 | The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent. ( Greenway, FL, 2001) |
"The effect of caffeine intake on weight loss maintenance has not been examined in humans." | 7.83 | Caffeine intake is related to successful weight loss maintenance. ( de Zwaan, M; Engeli, S; Feller, S; Hilbert, A; Icken, D; Mayr, A; Müller, A, 2016) |
"To describe a case of possible caffeine-induced seizure in a patient taking an over-the-counter weight loss supplement." | 7.79 | Potential toxicity of caffeine when used as a dietary supplement for weight loss. ( Brown, S; Odle, B; Pendleton, M; Thomas, CM, 2013) |
"To clarify whether there were any differences in basal metabolic rate (BMR) and thermogenic response to caffeine in individual obese women, and if so, whether such differences affected weight loss, the basal and resting metabolic rates at 30 min after a caffeine loading test (4 mg/kg ideal body weight, per os) were measured in 136 obese women and ten lean age-matched controls." | 7.69 | Relationship between basal metabolic rate, thermogenic response to caffeine, and body weight loss following combined low calorie and exercise treatment in obese women. ( Kondo, M; Sakane, N; Umekawa, T; Yoshida, T, 1994) |
" Bariatric surgery resulted in faster absorption and normalized pharmacokinetic parameters, prompting an increase in paracetamol bioavailability." | 6.84 | Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism. ( Boix, DB; Civit, E; de la Torre, R; Farré, M; Goday Arno, A; Grande, L; Langohr, K; Le Roux, JAF; Lí Carbó, M; Nino, OC; Papaseit, E; Pera, M; Pérez-Mañá, C; Ramon, JM; Rodríguez-Morató, J, 2017) |
"Caffeine was found to be present in concentrations that represent doses from 25." | 5.43 | Liquid chromatographic determination of caffeine and adrenergic stimulants in food supplements sold in Brazilian e-commerce for weight loss and physical fitness. ( Dal Molin, TR; de Carvalho, LM; Müller, LS; Seiffert, H; Viana, C; Zemolin, GM, 2016) |
" The diabetes risk was negatively related to the consumption in a dose-response manner." | 5.33 | Coffee, tea and diabetes: the role of weight loss and caffeine. ( Axen, KV; Boozer, CN; Greenberg, JA; Schnoll, R, 2005) |
"Ephedrine is a sympathicomimetic agent that stimulates the central nervous and cardiovascular systems and causes bronchodilatation." | 5.31 | [Ephedrine and ephedra in weight loss products and other preparations]. ( Stricker, BH; van der Hooft, CS, 2002) |
"The objective of this study was to examine the effect of caffeine on judo performance, perceived exertion, and plasma lactate response when ingested during recovery from a 5-day weight loss period." | 5.19 | Caffeine ingestion after rapid weight loss in judo athletes reduces perceived effort and increases plasma lactate concentration without improving performance. ( Bertuzzi, R; Felippe, LJ; Lima-Silva, AE; Lopes-Silva, JP; Silva-Cavalcante, MD, 2014) |
"To evaluate the effects of combination caffeine/ephedrine and leptin A-200 on visceral fat mass and weight loss over 24 weeks." | 5.17 | The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss. ( Fujioka, K; Greenway, FL; Liu, AG; Smith, SR, 2013) |
"Green tea (epigallocatechin gallate + caffeine) and protein each were shown to improve body weight maintenance after weight loss." | 5.14 | Green tea catechin plus caffeine supplementation to a high-protein diet has no additional effect on body weight maintenance after weight loss. ( Hursel, R; Westerterp-Plantenga, MS, 2009) |
"Investigation of the effect of a green tea-caffeine mixture on weight maintenance after body weight loss in moderately obese subjects in relation to habitual caffeine intake." | 5.11 | Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. ( Kovacs, EM; Lejeune, MP; Westerterp-Plantenga, MS, 2005) |
"Caffeine ingestion decreases the insulin sensitivity index (ISI) for an oral-glucose-tolerance test (OGTT) and decreases insulin-induced glucose disposal in lean male subjects during a hyperinsulinemic clamp." | 5.11 | Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss. ( Belfie, LM; Chown, SE; Conquer, JA; Duncan, AM; Graham, TE; McLaren, DH; Petrie, HJ, 2004) |
"To evaluate the effect of a dietary supplement containing herbal caffeine (70 mg/dose) and ephedra (24 mg/dose; C&E) on metabolic rate, weight loss, body composition, and safety parameters." | 5.11 | Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition. ( Blanchard, D; De Jonge, L; Frisard, M; Greenway, FL; Smith, SR, 2004) |
"To examine long-term safety and efficacy for weight loss of an herbal Ma Huang and Kola nut supplement (90/192 mg/day ephedrine alkaloids/caffeine)." | 5.10 | Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. ( Blanchard, D; Boozer, CN; Daly, PA; Homel, P; Meredith, T; Nasser, JA; Solomon, JL; Strauss, R, 2002) |
"To compare caffeine pharmacokinetics (200 mg single oral dose) between obese and lean subjects and in obese subjects prior to and following weight reduction." | 5.08 | Caffeine pharmacokinetics in obesity and following significant weight reduction. ( Berry, EM; Caraco, Y; Levy, M; Zylber-Katz, E, 1995) |
"In previous separate studies, dexfenfluramine (DF) and ephedrine/caffeine (EC) have been shown to promote weight loss in obese patients as compared with placebo." | 5.07 | Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice. ( Ahlstrøm, F; Breum, L; Frimodt-Møller, J; Pedersen, JK, 1994) |
"The sympathomimetic agent ephedrine has potent thermogenic and anti-obesity properties in rodents." | 5.07 | The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. ( Astrup, A; Breum, L; Hein, P; Quaade, F; Toubro, S, 1992) |
"This systematic review and meta-analysis of randomized controlled trials (RCTs) was performed to summarize the effect of caffeine intake on weight loss." | 5.01 | The effects of caffeine intake on weight loss: a systematic review and dos-response meta-analysis of randomized controlled trials. ( Akbari, M; Asemi, Z; Esmaillzadeh, A; Kolahdooz, F; Lankarani, KB; Mazoochi, M; Nadi-Ravandi, S; Saneei, P; Tabrizi, R, 2019) |
" RCTs that evaluated GTCs with or without caffeine and that reported BMI, body weight, WC, or WHR were included." | 4.86 | Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. ( Baker, WL; Coleman, CI; Lanosa, M; Matthews, LJ; Phung, OJ; Thorne, A, 2010) |
" Tools for obesity management, including consumption of caffeine, capsaicin and different teas such as green, white and oolong tea, have been proposed as strategies for weight loss and weight maintenance, as they may increase energy expenditure (4-5%), fat oxidation (10-16%) and have been proposed to counteract the decrease in metabolic rate that is present during weight loss." | 4.86 | Thermogenic ingredients and body weight regulation. ( Hursel, R; Westerterp-Plantenga, MS, 2010) |
"Different outcomes of the effect of green tea on weight loss (WL) and weight maintenance (WM) have been reported in studies with subjects differing in ethnicity and habitual caffeine intake." | 4.85 | The effects of green tea on weight loss and weight maintenance: a meta-analysis. ( Hursel, R; Viechtbauer, W; Westerterp-Plantenga, MS, 2009) |
"Ephedra and ephedrine sometimes are used for weight loss or enhanced athletic performance, but the efficacy and safety of these compounds are uncertain." | 4.82 | Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. ( Gagné, J; Hardy, ML; Jungvig, L; Maglione, M; Mojica, WA; Morton, SC; Rhodes, SL; Shekelle, PG; Suttorp, MJ, 2003) |
"Since passage of the Dietary Supplement Health and Education Act of 1994, the sale of herbal dietary supplements containing caffeine and ephedrine for weight loss has become widespread in the United States." | 4.81 | The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent. ( Greenway, FL, 2001) |
"The effect of caffeine intake on weight loss maintenance has not been examined in humans." | 3.83 | Caffeine intake is related to successful weight loss maintenance. ( de Zwaan, M; Engeli, S; Feller, S; Hilbert, A; Icken, D; Mayr, A; Müller, A, 2016) |
"To describe a case of possible caffeine-induced seizure in a patient taking an over-the-counter weight loss supplement." | 3.79 | Potential toxicity of caffeine when used as a dietary supplement for weight loss. ( Brown, S; Odle, B; Pendleton, M; Thomas, CM, 2013) |
"The administration of ephedrine and caffeine (E+C) has been proposed to promote weight loss by increasing energy expenditure and decreasing food intake." | 3.70 | Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine. ( Colman, RJ; Kemnitz, JW; Ramsey, JJ; Swick, AG, 1998) |
"It was demonstrated that the anti-obesity effects of oolong tea in high-fat diet-treated mice might be due partly to the enhancing effect of caffeine isolated from oolong tea on noradrenaline-induced lipolysis in adipose tissue, and to the inhibitory action of some other substance in oolong tea on pancreatic lipase activity." | 3.70 | Anti-obesity action of oolong tea. ( Han, LK; Kimura, Y; Li, J; Okuda, H; Takaku, T, 1999) |
" Pharmaceutical costs were evaluated in 73 of 220 subjects taking medications for diabetes, hyperlipidemia, or hypertension before and after treatment using fenfluramine with mazindol or phentermine." | 3.70 | Pharmaceutical cost savings of treating obesity with weight loss medications. ( Bray, GA; Greenway, FL; Rood, JC; Ryan, DH; Smith, SR; Tucker, EW, 1999) |
"To clarify whether there were any differences in basal metabolic rate (BMR) and thermogenic response to caffeine in individual obese women, and if so, whether such differences affected weight loss, the basal and resting metabolic rates at 30 min after a caffeine loading test (4 mg/kg ideal body weight, per os) were measured in 136 obese women and ten lean age-matched controls." | 3.69 | Relationship between basal metabolic rate, thermogenic response to caffeine, and body weight loss following combined low calorie and exercise treatment in obese women. ( Kondo, M; Sakane, N; Umekawa, T; Yoshida, T, 1994) |
" Bariatric surgery resulted in faster absorption and normalized pharmacokinetic parameters, prompting an increase in paracetamol bioavailability." | 2.84 | Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism. ( Boix, DB; Civit, E; de la Torre, R; Farré, M; Goday Arno, A; Grande, L; Langohr, K; Le Roux, JAF; Lí Carbó, M; Nino, OC; Papaseit, E; Pera, M; Pérez-Mañá, C; Ramon, JM; Rodríguez-Morató, J, 2017) |
"Infertility is a prevalent problem that has significant consequences for individuals, families, and the community." | 2.72 | Preconception lifestyle advice for people with infertility. ( Boedt, T; Dancet, E; Lie Fong, S; Matthys, C; Vanhove, AC; Vercoe, MA, 2021) |
"Body weight reductions were 0." | 2.70 | Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients. ( Andersen, T; Fogh, J, 2001) |
" Adverse events were negligible and did not differ between the CE and PL groups." | 2.69 | Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents. ( Erhardt, E; Jeges, S; Molnár, D; Török, K, 2000) |
"The across-treatment weight loss observed, when combined with data on fluid-disease relationships, suggests that optimal fluid intake may be higher than common recommendations." | 2.69 | The effect of caffeinated, non-caffeinated, caloric and non-caloric beverages on hydration. ( Bannick, KE; Grandjean, AC; Haven, MC; Reimers, KJ, 2000) |
"Obesity is a serious health problem throughout the world." | 2.41 | Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview. ( Bagchi, D; Bagchi, M; DiFerdinando, D; Preuss, HG, 2002) |
"Obesity is characterised by pathophysiological defects affecting both sides of the energy balance equation." | 2.40 | What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice. ( Astrup, A; Lundsgaard, C, 1998) |
"Caffeine was found to be present in concentrations that represent doses from 25." | 1.43 | Liquid chromatographic determination of caffeine and adrenergic stimulants in food supplements sold in Brazilian e-commerce for weight loss and physical fitness. ( Dal Molin, TR; de Carvalho, LM; Müller, LS; Seiffert, H; Viana, C; Zemolin, GM, 2016) |
" Moreover, they also may become contaminated with toxic metals." | 1.39 | How safe is the use of herbal weight-loss products sold over the internet? ( Celbis, O; Erdogan, S; Kapucu, H; Karakoc, Y; Onal, Y; Ozdemir, B; Sahin, I, 2013) |
" The diabetes risk was negatively related to the consumption in a dose-response manner." | 1.33 | Coffee, tea and diabetes: the role of weight loss and caffeine. ( Axen, KV; Boozer, CN; Greenberg, JA; Schnoll, R, 2005) |
"Necrosis was not present in the rats fed ephedrine alone." | 1.32 | Mechanism of the alcohol cyclic pattern: role of catecholamines. ( Bardag-Gorce, F; French, BA; French, SW; Fu, P; Li, J, 2003) |
"Ephedrine is a sympathicomimetic agent that stimulates the central nervous and cardiovascular systems and causes bronchodilatation." | 1.31 | [Ephedrine and ephedra in weight loss products and other preparations]. ( Stricker, BH; van der Hooft, CS, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 17 (23.29) | 18.2507 |
2000's | 28 (38.36) | 29.6817 |
2010's | 26 (35.62) | 24.3611 |
2020's | 2 (2.74) | 2.80 |
Authors | Studies |
---|---|
Boedt, T | 1 |
Vanhove, AC | 1 |
Vercoe, MA | 1 |
Matthys, C | 1 |
Dancet, E | 1 |
Lie Fong, S | 1 |
Dangol, M | 1 |
Kim, S | 1 |
Li, CG | 1 |
Fakhraei Lahiji, S | 1 |
Jang, M | 1 |
Ma, Y | 1 |
Huh, I | 1 |
Jung, H | 1 |
Goday Arno, A | 1 |
Farré, M | 1 |
Rodríguez-Morató, J | 1 |
Ramon, JM | 1 |
Pérez-Mañá, C | 1 |
Papaseit, E | 1 |
Civit, E | 1 |
Langohr, K | 1 |
Lí Carbó, M | 1 |
Boix, DB | 1 |
Nino, OC | 1 |
Le Roux, JAF | 1 |
Pera, M | 1 |
Grande, L | 1 |
de la Torre, R | 1 |
Vázquez Cisneros, LC | 1 |
López-Uriarte, P | 1 |
López-Espinoza, A | 1 |
Navarro Meza, M | 1 |
Espinoza-Gallardo, AC | 1 |
Guzmán Aburto, MB | 1 |
Arent, SM | 1 |
Walker, AJ | 1 |
Pellegrino, JK | 1 |
Sanders, DJ | 1 |
McFadden, BA | 1 |
Ziegenfuss, TN | 1 |
Lopez, HL | 1 |
Buchanan, SR | 1 |
Karabulut, M | 1 |
Tabrizi, R | 1 |
Saneei, P | 1 |
Lankarani, KB | 1 |
Akbari, M | 1 |
Kolahdooz, F | 1 |
Esmaillzadeh, A | 1 |
Nadi-Ravandi, S | 1 |
Mazoochi, M | 1 |
Asemi, Z | 1 |
Jayawardena, R | 1 |
Sooriyaarachchi, P | 1 |
Ranasinghe, P | 1 |
Perera, A | 1 |
Hills, AP | 1 |
Liu, AG | 1 |
Smith, SR | 4 |
Fujioka, K | 1 |
Greenway, FL | 6 |
Zhang, Y | 1 |
Balilionis, G | 1 |
Casaru, C | 1 |
Geary, C | 1 |
Schumacker, RE | 1 |
Neggers, YH | 1 |
Curtner-Smith, MD | 1 |
Richardson, MT | 1 |
Bishop, PA | 1 |
Green, JM | 1 |
Haddock, CK | 1 |
Poston, WS | 1 |
Lagrotte, C | 1 |
Klotz, AA | 1 |
Oliver, TL | 1 |
Vander Veur, SS | 1 |
Foster, GD | 1 |
Jebb, SA | 1 |
Moore, C | 1 |
Roberts, SA | 1 |
Reeves, RS | 1 |
Bolton, MP | 1 |
Foreyt, JP | 1 |
Lopes-Silva, JP | 1 |
Felippe, LJ | 1 |
Silva-Cavalcante, MD | 1 |
Bertuzzi, R | 1 |
Lima-Silva, AE | 1 |
Bajerska, J | 1 |
Mildner-Szkudlarz, S | 1 |
Walkowiak, J | 1 |
Kolasa, KM | 1 |
Firnhaber, G | 1 |
Haven, K | 1 |
Icken, D | 1 |
Feller, S | 1 |
Engeli, S | 1 |
Mayr, A | 1 |
Müller, A | 1 |
Hilbert, A | 1 |
de Zwaan, M | 1 |
Viana, C | 1 |
Zemolin, GM | 1 |
Müller, LS | 1 |
Dal Molin, TR | 1 |
Seiffert, H | 1 |
de Carvalho, LM | 1 |
Levy, Y | 1 |
Narotzki, B | 1 |
Reznick, AZ | 1 |
Hursel, R | 3 |
Westerterp-Plantenga, MS | 5 |
Wang, S | 1 |
Sparks, LM | 1 |
Xie, H | 1 |
de Jonge, L | 2 |
Viechtbauer, W | 1 |
Phung, OJ | 1 |
Baker, WL | 1 |
Matthews, LJ | 1 |
Lanosa, M | 1 |
Thorne, A | 1 |
Coleman, CI | 1 |
Ballard, SL | 1 |
Wellborn-Kim, JJ | 1 |
Clauson, KA | 1 |
Dalbo, VJ | 1 |
Roberts, MD | 1 |
Stout, JR | 1 |
Kerksick, CM | 1 |
Rains, TM | 1 |
Agarwal, S | 1 |
Maki, KC | 1 |
Burke, LM | 1 |
Stear, SJ | 1 |
Lobb, A | 1 |
Ellison, M | 1 |
Castell, LM | 1 |
Berger, RE | 1 |
Ganetsky, M | 1 |
Frisoli, TM | 1 |
Schmieder, RE | 1 |
Grodzicki, T | 1 |
Messerli, FH | 1 |
Ozdemir, B | 1 |
Sahin, I | 1 |
Kapucu, H | 1 |
Celbis, O | 1 |
Karakoc, Y | 1 |
Erdogan, S | 1 |
Onal, Y | 1 |
Montagnana, M | 1 |
Favaloro, EJ | 1 |
Lippi, G | 1 |
Pendleton, M | 1 |
Brown, S | 1 |
Thomas, CM | 1 |
Odle, B | 1 |
van der Hooft, CS | 1 |
Stricker, BH | 1 |
Shekelle, PG | 1 |
Hardy, ML | 1 |
Morton, SC | 1 |
Maglione, M | 1 |
Mojica, WA | 1 |
Suttorp, MJ | 1 |
Rhodes, SL | 1 |
Jungvig, L | 1 |
Gagné, J | 1 |
Li, J | 2 |
French, BA | 1 |
Fu, P | 1 |
Bardag-Gorce, F | 1 |
French, SW | 1 |
Preuss, HG | 1 |
DiFerdinando, D | 1 |
Bagchi, M | 1 |
Bagchi, D | 1 |
Zimmerman, E | 1 |
Wylie-Rosett, J | 1 |
Kovacs, EM | 2 |
Lejeune, MP | 2 |
Nijs, I | 1 |
Petrie, HJ | 1 |
Chown, SE | 1 |
Belfie, LM | 1 |
Duncan, AM | 1 |
McLaren, DH | 1 |
Conquer, JA | 1 |
Graham, TE | 1 |
Blanchard, D | 2 |
Frisard, M | 1 |
Coffey, CS | 1 |
Steiner, D | 1 |
Baker, BA | 1 |
Allison, DB | 1 |
Zhao, X | 1 |
Liu, SJ | 1 |
Zhang, J | 1 |
Strong, R | 1 |
Aronowski, J | 1 |
Grotta, JC | 1 |
Greenberg, JA | 2 |
Axen, KV | 1 |
Schnoll, R | 1 |
Boozer, CN | 4 |
Hackman, RM | 1 |
Havel, PJ | 1 |
Schwartz, HJ | 1 |
Rutledge, JC | 1 |
Watnik, MR | 1 |
Noceti, EM | 1 |
Stohs, SJ | 1 |
Stern, JS | 1 |
Keen, CL | 1 |
Belza, A | 1 |
Frandsen, E | 1 |
Kondrup, J | 1 |
Geliebter, A | 1 |
Caraco, Y | 1 |
Zylber-Katz, E | 1 |
Berry, EM | 1 |
Levy, M | 1 |
Buemann, B | 1 |
Marckmann, P | 1 |
Christensen, NJ | 1 |
Astrup, A | 4 |
Yoshida, T | 1 |
Sakane, N | 1 |
Umekawa, T | 1 |
Kondo, M | 1 |
Toubro, S | 3 |
Breum, L | 4 |
Quaade, F | 3 |
Pedersen, JK | 1 |
Ahlstrøm, F | 1 |
Frimodt-Møller, J | 1 |
Astrup, AV | 1 |
Daly, PA | 3 |
Krieger, DR | 2 |
Dulloo, AG | 3 |
Young, JB | 2 |
Landsberg, L | 2 |
Monnin, S | 1 |
Schiller, MR | 1 |
Sachs, L | 1 |
Smith, AM | 1 |
McCarty, MF | 1 |
Ramsey, JJ | 1 |
Colman, RJ | 1 |
Swick, AG | 1 |
Kemnitz, JW | 1 |
Lundsgaard, C | 1 |
Han, LK | 1 |
Takaku, T | 1 |
Kimura, Y | 1 |
Okuda, H | 1 |
Ryan, DH | 1 |
Bray, GA | 1 |
Rood, JC | 1 |
Tucker, EW | 1 |
Grandjean, AC | 1 |
Reimers, KJ | 1 |
Bannick, KE | 1 |
Haven, MC | 1 |
Molnár, D | 1 |
Török, K | 1 |
Erhardt, E | 1 |
Jeges, S | 1 |
Raum, WJ | 1 |
DeLany, JP | 1 |
Nasser, JA | 2 |
Heymsfield, SB | 1 |
Wang, V | 1 |
Chen, G | 1 |
Solomon, JL | 2 |
Andersen, T | 1 |
Fogh, J | 1 |
Fischer, JW | 1 |
Reading, SA | 1 |
Hillyer, L | 1 |
Woodward, B | 1 |
Barclay, JK | 1 |
Homel, P | 1 |
Strauss, R | 1 |
Meredith, T | 1 |
Hein, P | 1 |
Williams, MH | 1 |
Kaplan, NM | 1 |
Ransil, BJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques in Drugs Metabolism.[NCT01086722] | Phase 1/Phase 2 | 52 participants (Actual) | Interventional | 2010-02-28 | Completed | ||
The Effect of Leptin A-200, Caffeine/Ephedrine and Their Combination Upon Weight Loss and Body Composition in Man[NCT01710722] | 45 participants (Actual) | Interventional | 2001-02-28 | Completed | |||
Effect of Coffee and Tea Consumption on Adolescent Weight Control - a Randomized Clinical Trial[NCT05181176] | 63 participants (Anticipated) | Interventional | 2021-01-01 | Recruiting | |||
Uncovering the 'ORIGINS' of Diabetes[NCT02226640] | 80 participants (Actual) | Observational | 2010-11-30 | Completed | |||
The Effect of Green Tea Supplementation Strategies on Fat Oxidation and Body Composition in Overweight Individuals[NCT04628624] | 30 participants (Actual) | Interventional | 2018-12-01 | Completed | |||
Long-term Effects of Green Tea on Gut Flora, Fat Absorption, Body Composition and Resting Energy Expenditure[NCT01556321] | 70 participants (Actual) | Interventional | 2012-06-30 | Completed | |||
Placebo Controlled, Randomized, Single Blinded Trial on the Effects of Greenselect Phytosome® on Weight Maintenance in Obese Women After a 3-month Weight Loss Intervention[NCT02542449] | Phase 4 | 40 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
The Effect of Metabolism-Boosting Beverages on 24 Hr Energy Expenditure[NCT01029236] | 30 participants (Actual) | Interventional | 2007-06-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
18 reviews available for caffeine and Weight Loss
Article | Year |
---|---|
Preconception lifestyle advice for people with infertility.
Topics: Alcohol Drinking; Bias; Caffeine; Central Nervous System Stimulants; Counseling; Diet, Healthy; Exer | 2021 |
Effects of green tea and its epigallocatechin (EGCG) content on body weight and fat mass\
in humans: a systematic review
Topics: Adiposity; Antioxidants; Body Weight; Caffeine; Catechin; Humans; Tea; Weight Loss | 2017 |
The effects of caffeine intake on weight loss: a systematic review and dos-response meta-analysis of randomized controlled trials.
Topics: Caffeine; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Humans; Weight Loss | 2019 |
Diet for a Healthy Lactating Woman.
Topics: Alcohol Drinking; Caffeine; Calcium, Dietary; Diet; Diet, Reducing; Diet, Vegetarian; Directive Coun | 2015 |
The effects of green tea on weight loss and weight maintenance: a meta-analysis.
Topics: Caffeine; Catechin; Humans; Obesity; Satiation; Tea; Weight Loss | 2009 |
The effects of green tea on weight loss and weight maintenance: a meta-analysis.
Topics: Caffeine; Catechin; Humans; Obesity; Satiation; Tea; Weight Loss | 2009 |
The effects of green tea on weight loss and weight maintenance: a meta-analysis.
Topics: Caffeine; Catechin; Humans; Obesity; Satiation; Tea; Weight Loss | 2009 |
The effects of green tea on weight loss and weight maintenance: a meta-analysis.
Topics: Caffeine; Catechin; Humans; Obesity; Satiation; Tea; Weight Loss | 2009 |
Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis.
Topics: Anthropometry; Body Mass Index; Body Weight; Caffeine; Catechin; Humans; Meta-Analysis as Topic; Pat | 2010 |
Thermogenic ingredients and body weight regulation.
Topics: Body Weight; Caffeine; Capsaicin; Energy Metabolism; Humans; Obesity; Oxidation-Reduction; Tea; Ther | 2010 |
Antiobesity effects of green tea catechins: a mechanistic review.
Topics: Adiposity; Animals; Anti-Obesity Agents; Appetite Depressants; Caffeine; Catechin; Drug Synergism; D | 2011 |
A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance--Part 19.
Topics: Athletic Performance; Caffeine; Dietary Supplements; Glycerol; Humans; Paullinia; Plant Extracts; Pl | 2011 |
Beyond salt: lifestyle modifications and blood pressure.
Topics: Alcohol Drinking; Biofeedback, Psychology; Blood Pressure; Caffeine; Central Nervous System Stimulan | 2011 |
The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent.
Topics: Aminophylline; Animals; Caffeine; Ephedrine; Humans; Obesity; Plant Preparations; Theophylline; Weig | 2001 |
Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.
Topics: Anti-Obesity Agents; Caffeine; Controlled Clinical Trials as Topic; Dietary Supplements; Ephedra; Ep | 2003 |
Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview.
Topics: Adrenergic beta-Agonists; Anti-Obesity Agents; Basal Metabolism; Caffeine; Citrus; Ephedra; Humans; | 2002 |
Nutrition therapy for hypertension.
Topics: Alcohol Drinking; Behavior Therapy; Caffeine; Diet; Exercise; Humans; Hypertension; Life Style; Meta | 2003 |
Coffee, diabetes, and weight control.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Caffeine; Coffee; Diabetes Mellitus; Epidemiolo | 2006 |
What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.
Topics: Adrenergic beta-Agonists; Animals; Appetite Depressants; Caffeine; Central Nervous System Stimulants | 1998 |
Herbal simulation of ephedrine and caffeine in treatment of obesity.
Topics: Appetite Depressants; Caffeine; Drug Therapy, Combination; Ephedrine; Humans; Obesity; Plant Prepara | 2002 |
Long-term effectiveness of nonpharmacological treatment of hypertension.
Topics: Alcohol Drinking; Blood Pressure; Caffeine; Calcium; Diet; Diet, Sodium-Restricted; Exercise; Humans | 1991 |
32 trials available for caffeine and Weight Loss
Article | Year |
---|---|
Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism.
Topics: Acetaminophen; Adolescent; Adult; Bariatric Surgery; Biomarkers; Caffeine; Female; Gastrectomy; Gast | 2017 |
The Combined Effects of Exercise, Diet, and a Multi-Ingredient Dietary Supplement on Body Composition and Adipokine Changes in Overweight Adults.
Topics: Adipokines; Adult; Body Composition; Caffeine; Caloric Restriction; Capsaicin; Citrus; Diet; Dietary | 2018 |
A caffeine containing weight loss supplement augments hemodynamic responses after exercise.
Topics: Adolescent; Adult; Blood Pressure; Caffeine; Cross-Over Studies; Dietary Supplements; Double-Blind M | 2018 |
The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss.
Topics: Absorptiometry, Photon; Adolescent; Adult; Body Composition; Body Weight; Caffeine; Double-Blind Met | 2013 |
Effects of caffeine and menthol on cognition and mood during simulated firefighting in the heat.
Topics: Affect; Body Temperature; Caffeine; Central Nervous System Stimulants; Cognition; Cross-Over Studies | 2014 |
Findings from an online behavioural weight management programme provided with or without a fortified diet beverage.
Topics: Adult; Beverages; Caffeine; Dextrins; Female; Humans; Middle Aged; Odds Ratio; Plant Extracts; Tea; | 2014 |
Caffeine ingestion after rapid weight loss in judo athletes reduces perceived effort and increases plasma lactate concentration without improving performance.
Topics: Adipose Tissue; Adult; Athletes; Athletic Performance; Body Composition; Body Weight; Caffeine; Cros | 2014 |
Effects of rye bread enriched with green tea extract on weight maintenance and the characteristics of metabolic syndrome following weight loss: a pilot study.
Topics: Blood Pressure; Body Mass Index; Body Weight Maintenance; Bread; Caffeine; Camellia sinensis; Catech | 2015 |
Green tea, weight loss and physical activity.
Topics: Aged; Blood Glucose; Body Mass Index; Caffeine; Catechin; Exercise; Female; Humans; Israel; Male; Ob | 2017 |
Green tea catechin plus caffeine supplementation to a high-protein diet has no additional effect on body weight maintenance after weight loss.
Topics: Adolescent; Adult; Appetite; Blood Glucose; Body Composition; Body Weight; Caffeine; Catechin; Dieta | 2009 |
Effect of gender on the metabolic impact of a commercially available thermogenic drink.
Topics: Adipose Tissue; Adult; Beverages; Body Composition; Caffeine; Catechin; Energy Metabolism; Exercise; | 2010 |
Effects of green tea on weight maintenance after body-weight loss.
Topics: Adolescent; Adult; Body Composition; Body Mass Index; Body Weight; Caffeine; Energy Metabolism; Fema | 2004 |
Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss.
Topics: Administration, Oral; Adult; Area Under Curve; Blood Glucose; C-Peptide; Caffeine; Central Nervous S | 2004 |
Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition.
Topics: Adolescent; Adult; Aged; Basal Metabolism; Body Composition; Caffeine; Diet; Double-Blind Method; Ep | 2004 |
A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment.
Topics: Adult; Anti-Obesity Agents; Benzyl Alcohols; Body Mass Index; Caffeine; Cola; Double-Blind Method; D | 2004 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.
Topics: Adult; Blood Glucose; Blood Pressure; Body Composition; Body Mass Index; Body Weight; Caffeine; Diet | 2006 |
Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.
Topics: Adipose Tissue; Anti-Obesity Agents; Body Composition; Body Weight; Caffeine; Calcium, Dietary; Came | 2007 |
Caffeine pharmacokinetics in obesity and following significant weight reduction.
Topics: Administration, Oral; Adolescent; Adult; Antipyrine; Body Mass Index; Caffeine; Female; Humans; Male | 1995 |
The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.
Topics: Body Composition; Caffeine; Cholesterol; Cholesterol, HDL; Diet, Reducing; Double-Blind Method; Ephe | 1994 |
The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.
Topics: Adult; Blood Glucose; Caffeine; Double-Blind Method; Drug Therapy, Combination; Energy Metabolism; E | 1993 |
Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
Topics: Adolescent; Adult; Aged; Blood Pressure; Body Mass Index; Caffeine; Double-Blind Method; Ephedrine; | 1994 |
Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.
Topics: Adult; Blood Pressure; Caffeine; Double-Blind Method; Drug Therapy, Combination; Ephedrine; Female; | 1993 |
Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity.
Topics: Adult; Aspirin; Caffeine; Drug Therapy, Combination; Energy Intake; Ephedrine; Female; Humans; Male; | 1993 |
The effect of caffeinated, non-caffeinated, caloric and non-caloric beverages on hydration.
Topics: Adult; Beverages; Blood Chemical Analysis; Body Fluids; Caffeine; Carbonated Beverages; Creatinine; | 2000 |
Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
Topics: Adipose Tissue; Adolescent; Apolipoproteins B; Blood Pressure; Body Composition; Caffeine; Double-Bl | 2000 |
The effect of an herbal dietary supplement containing ephedrine and caffeine on oxygen consumption in humans.
Topics: Caffeine; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Ephedrine; Female; Humans; O | 2000 |
An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial.
Topics: Adult; Anthropometry; Blood Pressure; Caffeine; Dietary Supplements; Double-Blind Method; Drug Combi | 2001 |
Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients.
Topics: Caffeine; Double-Blind Method; Female; Gastric Emptying; Humans; Ilex paraguariensis; Male; Obesity; | 2001 |
Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.
Topics: Blood Glucose; Blood Pressure; Body Composition; Body Weight; Caffeine; Cholesterol; Cholesterol, HD | 2002 |
The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
Topics: Administration, Oral; Adult; Analysis of Variance; Blood Pressure; Caffeine; Chemotherapy, Adjuvant; | 1992 |
Ephedrine, caffeine and aspirin promote weight loss in obese subjects.
Topics: Adult; Aspirin; Caffeine; Drug Therapy, Combination; Ephedrine; Female; Humans; Male; Obesity; Weigh | 1990 |
23 other studies available for caffeine and Weight Loss
Article | Year |
---|---|
Anti-obesity effect of a novel caffeine-loaded dissolving microneedle patch in high-fat diet-induced obese C57BL/6J mice.
Topics: Administration, Cutaneous; Animals; Anti-Obesity Agents; Caffeine; Cell Survival; Cholesterol; Diet, | 2017 |
Availability and composition of weight-loss supplements in Sri Lanka.
Topics: Anti-Obesity Agents; Caffeine; Dietary Supplements; Garcinia; Humans; Obesity; Plants; Sri Lanka; Te | 2020 |
Caffeine intake is related to successful weight loss maintenance.
Topics: Adult; Beverages; Body Weight Maintenance; Caffeine; Cross-Sectional Studies; Exercise; Female; Germ | 2016 |
Liquid chromatographic determination of caffeine and adrenergic stimulants in food supplements sold in Brazilian e-commerce for weight loss and physical fitness.
Topics: Brazil; Caffeine; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Dietary S | 2016 |
Subtyping obesity with microarrays: implications for the diagnosis and treatment of obesity.
Topics: Adult; Algorithms; Anthropometry; Caffeine; Cluster Analysis; Diet; Energy Intake; Ephedra; Female; | 2009 |
Effects of commercial energy drink consumption on athletic performance and body composition.
Topics: Adolescent; Adult; Anaerobic Threshold; Athletic Performance; Beverages; Body Composition; Caffeine; | 2010 |
An over-the-counter weight-loss supplement with a toxicity that may be unexpectedly difficult to treat.
Topics: Adult; Caffeine; Dietary Supplements; Female; Humans; Hypokalemia; Nonprescription Drugs; Poisoning; | 2012 |
How safe is the use of herbal weight-loss products sold over the internet?
Topics: Anti-Obesity Agents; Caffeine; Cyclobutanes; Drug Contamination; Internet; Metals; Nonprescription D | 2013 |
Coffee intake and cardiovascular disease: virtue does not take center stage.
Topics: Adult; Animals; Beverages; Caffeine; Cardiovascular Diseases; Chlorogenic Acid; Cholesterol; Coffee; | 2012 |
Potential toxicity of caffeine when used as a dietary supplement for weight loss.
Topics: Adult; Caffeine; Dietary Supplements; Epilepsy, Tonic-Clonic; Female; Humans; Nonprescription Drugs; | 2013 |
[Ephedrine and ephedra in weight loss products and other preparations].
Topics: Adverse Drug Reaction Reporting Systems; Appetite Depressants; Arrhythmias, Cardiac; Caffeine; Centr | 2002 |
Mechanism of the alcohol cyclic pattern: role of catecholamines.
Topics: Alanine Transaminase; Animals; Caffeine; Catecholamines; Drug Synergism; Ephedrine; Ethanol; Liver; | 2003 |
Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats.
Topics: Animals; Behavior, Animal; Caffeine; Drug Combinations; Drug Therapy, Combination; Ethanol; Infarcti | 2005 |
Coffee, tea and diabetes: the role of weight loss and caffeine.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Caffeine; Coffee; Confidence Intervals; Diabetes Mellit | 2005 |
Adverse drug reactions in Canada.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Anemia, Hemolytic, Autoimmune; Anti-Infective Agents; | 2005 |
Relationship between basal metabolic rate, thermogenic response to caffeine, and body weight loss following combined low calorie and exercise treatment in obese women.
Topics: Adult; Basal Metabolism; Body Temperature Regulation; Caffeine; Diet, Reducing; Energy Intake; Exerc | 1994 |
Nutritional concerns of women with breast cancer.
Topics: Adult; Aged; Attitude to Health; Body Weight; Breast Neoplasms; Caffeine; Diet; Dietary Fats; Female | 1993 |
Optimizing exercise for fat loss.
Topics: Adipose Tissue; Aerobiosis; Caffeine; Energy Metabolism; Exercise; Humans; Lipid Metabolism; Mathema | 1995 |
Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine.
Topics: Animals; Blood Glucose; Body Composition; Caffeine; Eating; Energy Metabolism; Ephedrine; Glucose To | 1998 |
Anti-obesity action of oolong tea.
Topics: Adipocytes; Animals; Caffeine; Cell-Free System; Dietary Fats; Eating; Female; Lipase; Lipolysis; Li | 1999 |
Pharmaceutical cost savings of treating obesity with weight loss medications.
Topics: Adolescent; Adult; Appetite Depressants; Caffeine; Cardiovascular Diseases; Diabetes Mellitus; Drug | 1999 |
Contractile function in vitro of slow-twitch skeletal muscle from weanling mice subjected to wasting malnutrition.
Topics: Animals; Caffeine; Eating; Female; Male; Mice; Muscle Contraction; Muscle Fibers, Slow-Twitch; Muscl | 2001 |
Ergogenic and ergolytic substances.
Topics: Amino Acids, Branched-Chain; Bicarbonates; Caffeine; Coenzymes; Humans; Nutritional Physiological Ph | 1992 |